Speakers
Robin Brittain
Sir Paul Curran
Jonathan Evans
Peter Howard
Erik Lenguerrand
Valsamis Markos
Simon Jameson
Derek Pegg
Andrew Price
Mike Reed
Mark Wilkinson
External Organisation
NJR Session and Launch of 21st NJR Annual Report
Chairs: Tim Wilton & Mike Reed
Agenda:
08:30 - 08:40 Welcome and setting the scene:
NJR reporting systems provide clinicians with feedback to enable improvement and enhancement Tim Wilton
08:40 - 08:45 Introduction to the key elements of the new NJR research strategy Chair: Professor Mark Wilkinson
To feature: NJR’s analysis and research work promotes an academic workforce - a selection of short presentations on supported research papers published during the past year
08:45 - 08:50 Survivorship of the dual-mobility construct in elective primary total hip replacement: A systematic review and meta-analysis including registry data Mr Jonathan Evans
08:50 - 08:55 Patient-Relevant Outcomes Following First Revision Total Knee Arthroplasty, by Diagnosis: An Analysis of Implant Survivorship, Mortality, Serious Medical Complications, and Patient-Reported Outcome Measures Utilizing the National Joint Registry Data Set Professor Andrew Price
08:55 - 09:00 Association between surgeon volume and patient outcomes after elective shoulder replacement surgery using data from the NJR and HES for England: population-based cohort study Markos Valsamis
09:00 - 09:05 Inequalities in provision of hip and knee replacement surgery for osteoarthritis by age, sex, and social deprivation in England between 2007-2017: A population-based cohort study of the National Joint Registry Dr Erik Lenguerrand
09:05 - 09:13 Q&A session on NJR Supported Research Chair: Professor Mark Wilkinson
09:13 - 09:18 Does investment in data collection and data validation justify the cost? Introduction to the key elements of the new NJR Data Quality Strategy Derek Pegg
09:19 - 09:32 Reflections on hospital and surgical performance: insight gained from the role as Chair of the NJR Surgical Performance Committee over the years Peter Howard
To feature:
09.27 An outlier surgeon - a surgeon’s experience of outlier status Simon Jameson
09:32 - 09:38 The legacy of COVID - the patients’ perspective. The impact on joint replacement surgery Robin Brittain, Patient Representative, NJR Board
09:38 - 09:48 Discussion and Q&A on the session presentations
09:48 - 09:52 Launch of NJR Annual Report 21 - Outline of report key highlights Professor Mike Reed
09:52 - 09:57 Summing up from session Chair Tim Wilton
09:57 - 10:00 NJR looking ahead Professor Sir Paul Curran
Robin Brittain is a patient representative for the NJR and has lived experience of musculoskeletal conditions, having been diagnosed in 1991 with Ankylosing Spondylitis and subsequently osteoarthritis and hip impingement to both hips. He volunteers across different activities including patient and peer support, advocacy and research for different organisations.
Professor Sir Paul Curran
Sir Paul was appointed Chair of the National Joint Registry in May 2022. President of City, University of London from 2010 to 2021, he served previously as Vice-Chancellor of Bournemouth University and Deputy Vice-Chancellor of the University of Southampton. A former academic at the Universities of Sheffield, Reading and Swansea, a NASA research scientist at Ames California and advisor to the European Space Agency, his research on environmental Earth observation has focused on climate change.
He is Chair of the Multiple Sclerosis Society, a Director of the Universities Superannuation Scheme and President of the Remote Sensing & Photogrammetry Society. He was Chair of the national Review Body on Doctors’ & Dentists’ Remuneration, Universities & Colleges Employers Association and The Conversation UK and was also a Member of the Natural Environment Research Council, Quality Assurance Agency, London Higher and Universities UK.
Sir Paul holds the degrees of BSc (Sheffield), MBA (Southampton), PhD and DSc (Bristol), Honorary DSc (Grand École ESCP, Paris & Peter the Great University, St Petersburg) and was Knighted in the 2016 New Year Honours for ‘services to higher education’.
Jonathan Evans is a Clinical Senior Lecturer in Trauma & Orthopaedics at the University of Exeter and Consultant hip surgeon at the Exeter Hip Unit. Having completed his doctorate at the University of Bristol, he now works on the data analysis team of the National Joint Registry (NJR). His research interests include Post-operative Periprosthetic Femoral Fractures (POPFF) and he is currently developing a Core Outcome Set for POPFF in preparation for trials in this area. He is working towards securing funding for an international collaborative RCT investigating the management of Prosthetic Joint Infection (PJI), the ROADMAP trial. He is also working to develop methods to assess the environmental impact of health technologies and embed this within both trials and observational research such as the NJR.
Peter is a Consultant Orthopaedic Surgeon from Derby, where he was appointed in 1991. His main areas of specialist interest have been hip and knee arthroplasty (primary and revision) and young adult hip problems. He has been involved with the NJR since 2002, initially as a regional clinical coordinator, and then as Chair of the Regional Clinical Coordinators Committee. He has been closely involved with the outcomes analysis for implants and surgeons, and the outlier management process, since this began in 2008. He now chairs the Surgical Performance and Implant Scrutiny Committees, and is a member of the NJR Board. He was President of the British Hip Society in 2017/18.
Erik is a Senior Lecturer in Medical Statistics and Quantitative Epidemiology at the University of Bristol, Translational Health Sciences, Musculoskeletal Research Unit lead by Professor Michael Whitehouse. He joined the University of Bristol in 2012 following medical statistician positions at the Medical Research Council and French Institute of Science and Technology for Transport, Development and Networks.
Erik has a particular interest in orthopaedic research to improve outcomes following joint replacement and is a contributor to the content development of the NJR Annual Report. He has produced over 100 manuscripts aiming to provide robust evidence that should inform best clinical practice https://pubmed.ncbi.nlm.nih.gov
@LenguerrandErik
Markos completed his medical studies at the University of Cambridge and entered specialty training in Trauma and Orthopaedics in Oxford. His DPhil at the University of Oxford was titled “Improving outcomes for patients having shoulder replacements: guiding patient selection, evaluating cost-effectiveness and informing NHS provision” and was funded by an NIHR Doctoral Fellowship.
Mr Simon Jameson is a consultant trauma and orthopaedic surgeon with an expertise in: primary hip and knee replacement, revision hip and knee replacement including reconstruction after failed trauma, peri-prosthetic joint infection and management of metastatic bone disease around the hip.
Simon’s research interests include: outcomes after joint replacement including influence of implant characteristics, management of peri-prosthetic joint infection and venous thromboembolic prophylaxis after hip and knee replacement.
Derek Pegg is a Consultant Trauma and Orthopaedic Surgeon at Leighton Hospital, Mid Cheshire Hospitals Foundation Trust, Crewe. Appointed in 1996, Derek developed a specialist interest in both hip and knee replacement surgery and (until very recently) their revision. He joined the NJR as a regional clinical coordinator (RCC) for the Northwest in 2012, becoming the deputy chair in 2017 and was appointed Chair of the RCC Committee in January 2021. He is also a member of the NJR Board, Executive Committee and Chair of the NJR Data Quality Committee.
Professor Andrew Price studied medicine at the University of Cambridge (Gonville and Caius College) before completing his clinical studies at St.Thomas' Hospital in London. For his Orthopaedic training he joined the Oxford training programme in 1997, becoming a Clinical Lecturer in NDORMS in 2001.
He was awarded a DPhil in 2003 through the University of Oxford (Worcester College), studying the Oxford partial knee replacement. He then completed a year of specialist Knee Fellowship training in Melbourne, returning to NDORMs and the Nuffield Orthopaedic Centre in 2004, where he was subsequently appointed Reader and Honorary Consultant in Knee Surgery.
In 2011, through the University of Oxford Recognition of Distinction exercise, he was made a Professor of Orthopaedic Surgery at NDORMS. His clinical work as a Consultant Knee Surgeon is based at the Nuffield Orthopaedic Centre, where he has recently been appointed to Clinical Director T&O. His research is based in NDORMS at the Botnar Centre, where he Leads the Knee Research Group.
Andrew is Fellow of Worcester College (Tutor for Graduate Entry Medical Studies), a member of the British Orthopaedic Association, member of the UK National Joint Registry Steering Committee and Past President of the British Association for Surgery of the Knee (BASK)
Professor Mike Reed is a full-time trauma and hip and knee joint replacement surgeon. He trained in the North of England and did fellowships in New Zealand. He leads Trauma and Orthopaedics at Northumbria, working with a team of 31 talented colleagues.
His research focuses on clinical outcomes and infection prevention, diagnosis and management. Professor Reed is on the NJR Board and executive of the National Joint Registry and Chairs the Annual Report, and the grant awards committee for Orthopaedic Research UK and NIHR (i4i PDA). He leads clinical trials for industry and NIHR, and works academically with the University of York.
He is leading the openPredictor project which aims to use data and artificial intelligence algorithms to predict the outcome of medical interventions including complications and health gain.
Professor Wilkinson's principal research interests are in the genetic and metabolic aspects of joint replacement, osteoarthritis, and other associated diseases. Professor Wilkinson is a key clinical collaborator in the Genetics of Osteoarthritis initiative. He and his collaborators have been instrumental in determining our current understanding of the genetic architecture of osteoarthritis. He conducted the first genome-wide scan into hip dysplasia, and into osteolysis and heterotopic ossification after hip replacement, He published the first study in humans to show that bisphosphonates may suppress bone loss after hip replacement and the first clinical trial to show that the human monoclonal antibody denosumab can inhibit osteolysis lesion activity. Other areas of research include exploration of the molecular mechanisms that underpin osteoarthritis development and identifying potential novel pharmacological strategies for its treatment. He has worked on the genetics of osteoarthritis has uncovered novel gene associations with severity and pattern of hip and knee OA, bone remodelling responses to disease, and hip shape. He also studied the systemic health effects of metal ion exposure after hip resurfacing has demonstrated effects on bone cells, cardiovascular, and other systems.
Professor Wilkinson’s principal funding sources are Versus Arthritis, NIHR, Wellcome, MRC, Royal College of Surgeons of England, Cavendish Foundation, John Charnley Trust and industry.
Tim Wilton trained at Oxford and at UCH medical school and in Orthopaedics at Nottingham, Harlow Wood, Derby and South Wales with travelling fellowships in N America, Strasbourg, Bern and Ljubljana. He has an entirely elective practice in lower limb arthroplasty and has specialised in knee replacement and knee revision surgery for the last 30 years. He has a lifetime personal experience of over 2500 hip and 3500 knee replacements.
Tim teaches widely on technical aspects of knee replacement and has been invited lecturer throughout the world and at the major European, North American and International Knee Surgery organisations.
Tim has been President of the BOA and of BASK, and Chairman of the Bone and Joint Journal.
He is NJR Medical Director and Vice Chair, NJR Board.